DALI-Study Group[Corporate Author] - Search Results

Year	Number of Results
2001	1
2002	2
2003	4
2004	1
2006	2
2009	2
2010	1
2015	2
2016	1
2024	0

1

No effects of atorvastatin (10 mg/d or 80 mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study.

Tsikas D, Pham VV, Suchy MT, van de Ree MA, Huisman MV, Frölich JC, Princen HM; DALI-Study Group. Tsikas D, et al. Pharmacol Res. 2015 Apr;94:1-8. doi: 10.1016/j.phrs.2015.01.004. Epub 2015 Feb 7. Pharmacol Res. 2015. PMID: 25662039 Clinical Trial.

2

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.

Dallinga-Thie GM, van Tol A, Hattori H, van Vark-van der Zee LC, Jansen H, Sijbrands EJ; DALI study group. Dallinga-Thie GM, et al. Diabetologia. 2006 Jul;49(7):1505-11. doi: 10.1007/s00125-006-0261-0. Epub 2006 Apr 28. Diabetologia. 2006. PMID: 16752169 Clinical Trial.

3

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort.

Abdul-Aziz MH, Lipman J, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Dulhunty J, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Roberts JA; DALI Study Group. Abdul-Aziz MH, et al. J Antimicrob Chemother. 2016 Jan;71(1):196-207. doi: 10.1093/jac/dkv288. Epub 2015 Oct 3. J Antimicrob Chemother. 2016. PMID: 26433783

4

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial.

van Venrooij FV, van de Ree MA, Bots ML, Stolk RP, Huisman MV, Banga JD; DALI Study Group. van Venrooij FV, et al. Diabetes Care. 2002 Jul;25(7):1211-6. doi: 10.2337/diacare.25.7.1211. Diabetes Care. 2002. PMID: 12087021 Clinical Trial.

5

Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.

Bosch T, Lennertz A, Schenzle D, Dräger J; Direct adsorption of lipoproteins (DALI) study group. Bosch T, et al. J Clin Apher. 2002;17(4):161-9. doi: 10.1002/jca.10035. J Clin Apher. 2002. PMID: 12494408 Clinical Trial.

6

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus.

van de Ree MA, Huisman MV, Princen HM, Meinders AE, Kluft C; DALI-Study Group. van de Ree MA, et al. Atherosclerosis. 2003 Jan;166(1):129-35. doi: 10.1016/s0021-9150(02)00316-7. Atherosclerosis. 2003. PMID: 12482559 Clinical Trial.

7

Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions.

Bosch T, Gahr S, Belschner U, Schaefer C, Lennertz A, Rammo J; DALI Study Group. Bosch T, et al. Ther Apher Dial. 2006 Jun;10(3):210-8. doi: 10.1111/j.1744-9987.2006.00336.x. Ther Apher Dial. 2006. PMID: 16817783 Clinical Trial.

8

Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant.

Berk-Planken II, Hoogerbrugge N, Stolk RP, Bootsma AH, Jansen H; DALI Study Group. Berk-Planken II, et al. Diabetes Care. 2003 Feb;26(2):427-32. doi: 10.2337/diacare.26.2.427. Diabetes Care. 2003. PMID: 12547874 Free article. Clinical Trial.

9

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.

Diabetes Atorvastin Lipid Intervention (DALI) Study Group. Diabetes Atorvastin Lipid Intervention (DALI) Study Group. Diabetes Care. 2001 Aug;24(8):1335-41. doi: 10.2337/diacare.24.8.1335. Diabetes Care. 2001. PMID: 11473066 Clinical Trial.

10

Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.

van Venrooij FV, Stolk RP, Banga JD, Sijmonsma TP, van Tol A, Erkelens DW, Dallinga-Thie GM; DALI Study Group. van Venrooij FV, et al. Diabetes Care. 2003 Apr;26(4):1216-23. doi: 10.2337/diacare.26.4.1216. Diabetes Care. 2003. PMID: 12663600 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year